Glu Mobile Inc. (NASDAQ:GLUU) reached a 52-week high during trading today, primarily on the back of its hit game application— Kim Kardashian: Hollywood. Currently, the stock is up more than 12%. Year-to-date, the stock has yielded returns of more than 53%. In an interview to Bloomberg today, Glu Mobile CEO Niccolo de Masi said the game may well be the company’s biggest hit this year. Glu Mobile Inc. (NASDAQ:GLUU) stock performance was 11.73% in last session and finished the day at $6.00. Traded volume was 17.48million shares in the last session and the average volume of the stock remained 3.65million shares. The beta of the stock remained 2.49. Glu Mobile Inc. (NASDAQ:GLUU) insider ownership is 0.20%.

Westmoreland Coal Co. (NASDAQ:WLB) announced that it priced its underwritten public offering of 1.46 million shares of common stock at $35.50 per share. The offering is expected to close on July 16, 2014, subject to customary closing conditions. The company also granted the underwriters a 30-day option to purchase up to 219,718 additional shares of common stock. Westmoreland Coal Company (NASDAQ:WLB) rose 6.24 percent to $39.31 Friday on volume of 1.01million shares. The intra-day range of the stock was $37.56 to $39.80. Westmoreland Coal Company (NASDAQ:WLB) has a market capitalization of $592.79million.

Investment analysts at HC Wainwright began coverage on shares of OXiGENE (NASDAQ:OXGN) in a note issued to investors on Thursday. The firm set a “buy” rating and a $6.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 136.22% from the stock’s previous close. OXiGENE Inc (NASDAQ:OXGN)’s stock on July 11, 2014 reported a increase of 5.42% to the closing price of $2.53. Its fifty two weeks range is $1.96 -$5.40. The total market capitalization recorded $52.40million. The overall volume in the last trading session was 939.32K shares. In its share capital, OXGN has 20.71million outstanding shares.

Boston Scientific Corporation (NYSE:BSX) Director Ernest Mario sold 10,000 shares of Boston Scientific stock on the open market in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $12.95, for a total transaction of $129,500.00. Following the sale, the director now directly owns 297,855 shares of the company’s stock, valued at approximately $3,857,222. On Friday, shares of Boston Scientific Corporation (NYSE:BSX) advanced 1.45% to close the day at $13.29. Company return on investment (ROI) is 2.10% and its monthly performance is recorded as 3.26%. Boston Scientific Corporation (NYSE:BSX) quarterly revenue growth is 2.78%.